News from 2004 CHPA conference in Washinton, D.C.
FDA Roundup: Biosimilars, Boxed Warning Added for CAR T-Cell Therapies
Check out important updates from the FDA for the week of April 15.
Episode 8: Stay in Sync with Innovations in Medication Decision Support
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
FDA Accepts GSK's BLA for 5-in-1 Meningococcal Vaccine
The company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.
Rx Roundup: Quiz of the Week — April 12, 2024
Test your pharmacy news knowledge with our weekly quiz.
FDA: Fasenra Approved As Add-On Maintenance Therapy for Severe Pediatric Asthma
Fasenra was initially approved in 2017 as an add on maintenance therapy in patients aged 12 years and older.
FDA Approves Antibiotic Ceftobiprole Medocaril for Injection for 3 Indications
The antibiotic was approved to treat Staphylococcus aureas bacteremia, acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia.
